Conjunctivitis Treatment Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast 2030
The conjunctivitis treatment market is
expected to reach a value of USD 4.9 billion globally by 2022, with a compound
annual growth rate (CAGR) of 5.1%. Conjunctivitis is an inflammation of the
membrane covering the eyeball, affecting the conjunctiva part of the eye during
the rainy season. It is easily contagious and rarely negatively affects human
eyes. Allergy-related conjunctivitis is very common and primarily occurs during
the hay fever season. Different strategies are employed in the market to treat
this condition.
Antibiotic eye drops or ointments are frequently used for
bacterial conjunctivitis. Antiviral drugs are administered if the
conjunctivitis is viral; nevertheless, viral conjunctivitis usually goes away
on its own. Lubricating eye drops assist preserve moisture in the eyes and
reduce symptoms. It is advised that patients with allergic conjunctivitis use
antihistamine eye drops. Steroid eye drops are used to treat patients in severe
situations.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/conjunctivitis-treatment-market
Impact of Covid-19
There are multiple effects of the COVID-19 pandemic on the
market for conjunctivitis treatments. Restrictions or lockdowns made it more
difficult to access medical facilities, which delayed the diagnosis and
treatment of conjunctivitis. Due to the pandemic's increased emphasis on
hygienic habits, there has been a rise in awareness of eye health, which may be
driving up demand for conjunctivitis treatments. Variations in the market have
resulted from supply chain disruptions that have affected the timely availability
of conjunctivitis treatments.
Growth Drivers
The market for conjunctivitis treatments is expanding as a
result of lifestyle modifications and an increase in allergic conjunctivitis
cases. The discovery of new medications and treatments through research and
development expenditures is another major driver of this market's expansion.
The market is expanding because hemorrhagic conjunctivitis is becoming more
common. Partnerships with healthcare professionals and heightened awareness
campaigns are two more factors propelling the market's expansion. The market is
expanding at a substantial rate due to rising awareness of eye-related
disorders.
The market is expanding dramatically due to the rise in
R&D efforts aimed at obtaining improved treatments. The market is expanding
due to rising healthcare costs and technology developments. Globalization,
industrialization, and rising air pollution are the main factors propelling the
market's expansion. Another reason contributing to the rise is the increasing prevalence
of bacterial conjunctivitis infections.
Segmentation
Drug Class
· Antibiotics
· Antivirals
· Antiallergic
· Artificial
Tears
Disease Type
· Bacterial
· Chemical
· Viral
· Allergic
Conjunctivitis
Route of
Administration
· Oral
· Topical
End-User
· Hospital
· Online
Pharmacies
· Retail
Pharmacies
Regional Outlook
· Asia
Pacific
· North
America
· Latin
America
· Europe
· Middle
East and Africa
Key Players
· Novartis
AG
· Cipla
Limited
· Abbvie
Inc
· Dr.
Reddy’s Laboratories limited
· Micro
Labs Limited
· Ocular
Therapeutix Inc
· Akkorn
operating company
· Vitaris
Inc
· Aurobindo
Pharma Limited
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/conjunctivitis-treatment-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment